Table 2. In-vitro susceptibility results of 12 Chryseobacterium indologenes isolates from blood samples.
| Drugs | Patient number (number of bacterial isolations) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # 1 (2) | # 2 (2) | # 3 (2) | # 4 (2) | # 5 (2) | # 6 (1) | # 7 (1) | # 8 (2) | # 9 (1) | # 10 (1) | # 11 (4) | # 12 (2) | |
| Ampicillin | >16 (R) | 16 (I) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | ||
| Amoxicillin/clavulanate | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | >16 (R) | 4 (S) | >16 (R) | ||||
| Cafazolin | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | |||||
| Cefalotin | >32 (R) | >32 (R) | >32 (R) | |||||||||
| Cefotaxime | >32 (R) | 16 (I) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | 32 (I) | >32 (R) | >32 (R) | >32 (R) |
| Ceftazidime | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | ≤1 (S) | 32 (R) | 16 (I) | 4 (S) | ||
| Cefepime | >32 (R) | >32 (R) | >32 (R) | 32 (R) | >32 (R) | 8 (S) | ≤1 (S) | 4 (S) | 4 (S) | ≤1 (S) | ||
| Piperacillin | >64 (R) | >64 (R) | >64 (R) | >64 (R) | 64 (I) | |||||||
| Piperacillin/tazobactam | 8/4 (S) | ≤4/4 (S) | 32/4 (I) | 16/4 (S) | ≥128/4 (R) | ≥128/4 (R) | ≥128/4 (R) | ≥128/4 (R) | ≤4/4 (S) | 64/4 (I) | ≥128/4 (R) | ≥128/4 (R) |
| Aztreonam | >32 (R) | >32 (R) | ||||||||||
| Meropenem | 8 (I) | >8 (R) | >8 (R) | >8 (R) | ||||||||
| Imipenem | >8 (R) | ≤0.5 (S) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | ≤0.25 (S) | >8 (R) | >8 (R) | >8 (R) |
| Gentamicin | >8 (R) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | >8 (R) | 8 (I) | ≤1 (S) | >8 (R) | >8 (R) | >8 (R) |
| Amikacin | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | >32 (R) | ≤2 (S) | >32 (R) | >32 (R) | >32 (R) |
| Ciprofloxacin | 1 (S) | 0.5 (S) | 1 (S) | 1 (S) | >2 (R) | 2 (I) | >2 (R) | ≤0.25 (S) | 0.5 (S) | 2 (I) | 0.5 (S) | |
| Levofloxacin | >4 (R) | 1 (S) | 0.5 (S) | |||||||||
| Trimethoprim-sulfamethoxazole | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | ≤1 (S) | 2 (S) | ≤1 (S) |
| Tigecycline | 1 (S) | >4 (R) | 4 (I) | ≤0.5 (S) | 4 (I) | >4 (R) | >4 (R) | |||||
| Tetracycline | >8 (R) | >8 (R) | ||||||||||
| Colistin | >8 (R) | >8 (R) | ||||||||||
R, resistant; I, intermediate; S, susceptible.